Company profile
Abingdon Health | Lateral Flow Test Manufacture and Development
Assay development and high-volume lateral flow test contract manufacturing. Helping you move faster, contain risks and embrace opportunities
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQzOTU3MDg4N2FkaXF6a2N4
Published 15 Oct 2024 12:26
CH01 | Transaction MzQzODQxODQyNWFkaXF6a2N4
Published 04 Oct 2024 10:37
RESOLUTIONS | Transaction QUQ5UEMyMDFhZGlxemtjeA | Paper/PDF filed
Published 22 Aug 2024 12:30
SH01 | Transaction MzQzMjk0MjczMWFkaXF6a2N4
Published 21 Aug 2024 13:07
Company registered at Companies House
1 Jan 2019 to 31 Dec 2020
"Lateral flow assays (LFA) are diagnostics tests where a liquid sample is applied to a small nitrocellulose membrane pre-patterned with reagents for detection of particular proteins, cells, chemical molecules or microorganisms. The existing market is worth circa $5.5bn per annum (Source: MarketsandMarkets 2017 Lateral Flow Assay Market Report) with LFAs u...
1 Jun 2018 to 28 Feb 2021
"As the world population continues to grow, we need to produce more food for more people, without compromising on animal welfare. Disease control in animals plays a major role in achieving this. Disease is estimated to reduce productivity in the livestock industry by 20% per annum, with losses from mortality, treatment costs, increased labour and reduced ...
